Cargando…
Tracking tumor evolution one-cell-at-a-time
Accumulating evidence suggests that intra-tumor heterogeneity (ITH) within tumor sub-populations is a major contributor to therapy resistance, with genomically distinct clonal populations exhibiting different therapeutic vulnerabilities. Here we employed single-cell transcriptomics in patient-derive...
Autores principales: | Sharma, Ankur, DasGupta, Ramanuj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512908/ https://www.ncbi.nlm.nih.gov/pubmed/31131309 http://dx.doi.org/10.1080/23723556.2019.1590089 |
Ejemplares similares
-
Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion
por: Mao, Chih-Ping, et al.
Publicado: (2014) -
TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity
por: Cartellieri, Marc, et al.
Publicado: (2013) -
Killing two birds with one stone: Blocking the mitochondrial pyruvate carrier to inhibit lactate uptake by cancer cells and radiosensitize tumors
por: Linden, Catherine Vander, et al.
Publicado: (2018) -
Radiotherapy supports protective tumor-specific immunity
por: Gupta, Anurag, et al.
Publicado: (2012) -
CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)